GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Electromedical Technologies Inc (OTCPK:EMED) » Definitions » 3-Year RORE %

EMED (Electromedical Technologies) 3-Year RORE % : 0.00% (As of Sep. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Electromedical Technologies 3-Year RORE %?

Return on Retained Earnings (RORE) is an indicator of a company's growth potential, it shows how much a company earns by reinvesting its retained earnings, i.e. profits after dividend payments. Electromedical Technologies's 3-Year RORE % for the quarter that ended in Sep. 2024 was 0.00%.

The industry rank for Electromedical Technologies's 3-Year RORE % or its related term are showing as below:

EMED's 3-Year RORE % is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: -8.405
* Ranked among companies with meaningful 3-Year RORE % only.

Electromedical Technologies 3-Year RORE % Historical Data

The historical data trend for Electromedical Technologies's 3-Year RORE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Electromedical Technologies 3-Year RORE % Chart

Electromedical Technologies Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
3-Year RORE %
- - - -29.47 -87.35

Electromedical Technologies Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
3-Year RORE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -78.55 -87.35 -84.91 - -

Competitive Comparison of Electromedical Technologies's 3-Year RORE %

For the Medical Devices subindustry, Electromedical Technologies's 3-Year RORE %, along with its competitors' market caps and 3-Year RORE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Electromedical Technologies's 3-Year RORE % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Electromedical Technologies's 3-Year RORE % distribution charts can be found below:

* The bar in red indicates where Electromedical Technologies's 3-Year RORE % falls into.



Electromedical Technologies 3-Year RORE % Calculation

Electromedical Technologies's 3-Year RORE % for the quarter that ended in Sep. 2024 is calculated as:

3-Year RORE %=( Most Recent EPS (Diluted)- First Period EPS (Diluted) )/( Cumulative EPS (Diluted) for 3-year -Cumulative Dividends per Share for 3-year )
=( - )/( -0.063-0 )
=/-0.063
=0.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of 3-Year RORE %, the most recent and first period EPS (Diluted) is the trailing twelve months (TTM) data ended in Sep. 2024 and 3-year before.


Electromedical Technologies  (OTCPK:EMED) 3-Year RORE % Explanation

Return on Retained Earnings (RORE) is important to investors because it reveals a company's efficiency and growth potential. A higher RORE indicates a higher return. A high RORE indicates that the company should reinvest profits into the business. A lower RORE suggests that the company should distribute profits to shareholders by paying out dividends, since those dollars aren't generating much additional growth for the company.

There are a several different ways to arrive at the Return on Retained Earnings. The simplest way to calculate it is by using published information on Earnings per Share (EPS) and Dividend per Share (DPS) over a selected period. Here, 3-year period is chosen.

Be Aware

Please keep in mind that the RORE is relative to the nature of the business and its competitors. If another company in the same sector is producing a lower return on retained earnings, it doesn’t necessarily mean it’s a bad investment. It may just suggest the company is older and no longer in a high growth stage. At such a stage in the business cycle, it would be expected to see a lower RORE and higher dividend payout.


Electromedical Technologies 3-Year RORE % Related Terms

Thank you for viewing the detailed overview of Electromedical Technologies's 3-Year RORE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Electromedical Technologies Business Description

Traded in Other Exchanges
N/A
Address
16413 North 91st Street, Suite C140, Scottsdale, AZ, USA, 85260
Electromedical Technologies Inc is a bioelectronics manufacturing company. It designs and develops simple-to-use bioelectronics therapy devices, which in major cases provide immediate and long-lasting pain relief across the broadest range of ailments. It focuses on improving global wellness for people suffering from various painful conditions. It develops and manufactures bioelectronics products.
Executives
Hymers Iii R. Leslie director 520 S GRAND AVENUE, STE 320, LOS ANGELES CA 90071
Lee Benson director PO BOX 41828, MESA AZ 41828
Donald J Steinberg 10 percent owner 3223 SUMAC ROAD, FALLBROOK CA 92028
Matthew Wolfson director, officer: CEO, CFO 16561 N. 92ND STREET, STE. 101, SCOTTSDALE AZ 85260

Electromedical Technologies Headlines

From GuruFocus